M. Sarzotti-Kelsoe

发表

Implementation of a three-tiered approach to identify and characterize anti-drug antibodies raised against HIV-specific broadly neutralizing antibodies

J. Weiner, D. Montefiori, M. Ackerman, 2020, Journal of immunological methods.

Optimization and qualification of a functional anti-drug antibody assay for HIV-1 bnAbs

J. Weiner, D. Montefiori, C. Labranche, 2020, Journal of immunological methods.

The long and the short of telomeres in bone marrow recipient SCID patients

X. Daniell, J. Whitesides, R. Buckley, 2011, Immunologic research.

Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

Lindsay N. Carpp, M. Andrasik, J. Kublin, 2021, Science.

Optimization and validation of a neutralizing antibody assay for HIV-1 in A3R5 cells.

X. Daniell, J. Kappes, D. Montefiori, 2014, Journal of immunological methods.

Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial

J. Kublin, D. Montefiori, N. Frahm, 2018, The lancet. HIV.

The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay.

N. Frahm, G. Ferrari, T. Denny, 2014, Journal of immunological methods.

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation

Lindsay N. Carpp, D. Montefiori, T. Wrin, 2021, medRxiv : the preprint server for health sciences.

Passively Transmitted gp41 Antibodies in Babies Born from HIV-1 Subtype C-Seropositive Women: Correlation between Fine Specificity and Protection

L. Lopalco, C. Gray, C. Pastori, 2012, Journal of Virology.

Post-Transplantation B Cell Function in Different Molecular Types of SCID

R. Buckley, B. Moser, E. Sajaroff, 2012, Journal of Clinical Immunology.

Thymic output, T-cell diversity, and T-cell function in long-term human SCID chimeras.

G. Sempowski, R. Buckley, B. Moser, 2009, Blood.

Implementation of a responsible conduct of research education program at Duke University School of Medicine

R. Califf, G. Samsa, J. Ariansen, 2019, Accountability in research.

Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission.

Haiyan Chen, H. Liao, B. Haynes, 2015, The Journal of clinical investigation.

Analysis of the HVTN 702 Phase 2b-3 HIV-1 vaccine trial in South Africa assessing RV144 antibody and T-cell correlates of HIV-1 acquisition risk.

Lindsay N. Carpp, J. Kublin, M. McElrath, 2022, The Journal of infectious diseases.

Qualified Biolayer Interferometry Avidity Measurements Distinguish the Heterogeneity of Antibody Interactions with Plasmodium falciparum Circumsporozoite Protein Antigens

S. Alam, A. Hill, S. Dennison, 2018, The Journal of Immunology.

Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.

Hongmei Gao, Marcella Sarzotti-Kelsoe, Daniel A Ozaki, 2014, Journal of immunological methods.

Optimization and qualification of an Fc Array assay for assessments of antibodies against HIV-1/SIV

J. Weiner, G. Alter, M. Ackerman, 2018, Journal of immunological methods.

Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial

Lindsay N. Carpp, Vicki C. Ashley, Allan C. deCamp, 2022 .

Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

Raphael Gottardo, Hongmei Gao, Bette T. Korber, 2013, Journal of Virology.

Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I–III Clinical Trials

Marcella Sarzotti-Kelsoe, T. Denny, Daniel A. Ozaki, 2009, PLoS medicine.

Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial

Lindsay N. Carpp, M. Andrasik, J. Kublin, 2021, medRxiv.

Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells.

Xuesong Yu, Gary Li, Hongmei Gao, 2012, Journal of immunological methods.

Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein

Allan C. deCamp, J. Kublin, S. Omarjee, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation

Lindsay N. Carpp, D. Montefiori, T. Wrin, 2021, medRxiv.

The Center for HIV/AIDS Vaccine Immunology (CHAVI) multi-site quality assurance program for cryopreserved human peripheral blood mononuclear cells.

Guido Ferrari, Marcella Sarzotti-Kelsoe, Wendy S. Stevens, 2014, Journal of immunological methods.

Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial

Lindsay N. Carpp, M. Andrasik, J. Kublin, 2023, Science Translational Medicine.

Post-Transplantation B Cell Function in Different Molecular Types of SCID

R. Buckley, B. Moser, E. Sajaroff, 2012, Journal of Clinical Immunology.

Profiles of neutralizing antibody response in chronically human immunodeficiency virus type 1 clade B'-infected former plasma donors from China naive to antiretroviral therapy.

D. Montefiori, Y. Ruan, K. Hong, 2012, The Journal of general virology.

Validation of a Triplex Pharmacokinetic Assay for Simultaneous Quantitation of HIV-1 Broadly Neutralizing Antibodies PGT121, PGDM1400, and VRC07-523-LS

G. Tomaras, D. Barouch, N. Yates, 2021, Frontiers in Immunology.

An Automated HIV-1 Env-Pseudotyped Virus Production for Global HIV Vaccine Trials

Heiko Zimmermann, Andreas Meyerhans, Anke Schultz, 2012, PloS one.

International Technology Transfer of a GCLP-Compliant HIV-1 Neutralizing Antibody Assay for Human Clinical Trials

Hongmei Gao, Marcella Sarzotti-Kelsoe, David C. Montefiori, 2012, PloS one.

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

Allan C. deCamp, J. Mullins, J. Weiner, 2023, EBioMedicine.

Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation

Lindsay N. Carpp, D. Montefiori, T. Wrin, 2021, Scientific Reports.

Profiling the neutralizing antibody response in chronically HIV-1 CRF07_BC-infected intravenous drug users naïve to antiretroviral therapy

D. Montefiori, Y. Ruan, K. Hong, 2017, Scientific Reports.

Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial

Lindsay N. Carpp, Vicki C. Ashley, Allan C. deCamp, 2018, The Journal of infectious diseases.

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

Allan C. deCamp, J. Mullins, J. Weiner, 2023, EBioMedicine.

Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I–III Clinical Trials

Daniel A. Ozaki, J. Hural, G. Stevens, 2009, PLoS medicine.

Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.

J. Mascola, D. Montefiori, R. Bailer, 2014, Journal of immunological methods.